{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:22:29Z","timestamp":1750220549722,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":58,"publisher":"ACM","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,21]]},"DOI":"10.1145\/3473258.3473270","type":"proceedings-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T21:02:28Z","timestamp":1639256548000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression and Prognosis of HER Family in Breast Cancer"],"prefix":"10.1145","author":[{"given":"You","family":"Huang","sequence":"first","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifang","family":"Wu","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Shen","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Liao","sequence":"additional","affiliation":[{"name":"Wuhan University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"320","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"e_1_3_2_1_1_1","volume-title":"Znaor A and Bray FJIjoc","author":"Ferlay J","year":"2019","unstructured":"Ferlay J , Colombet M , Soerjomataram I , Mathers C , Parkin D , Pi\u00f1eros M , Znaor A and Bray FJIjoc . 2019 . Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. 144: 1941-1953. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Pi\u00f1eros M, Znaor A and Bray FJIjoc. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. 144: 1941-1953."},{"key":"e_1_3_2_1_2_1","volume-title":"Barazvan B and Soleimani Rad JJB","author":"Velaei K","year":"2016","unstructured":"Velaei K , Samadi N , Barazvan B and Soleimani Rad JJB . 2016 . Tumor microenvironment-mediated chemoresistance in breast cancer. 30: 92-100. Velaei K, Samadi N, Barazvan B and Soleimani Rad JJB. 2016. Tumor microenvironment-mediated chemoresistance in breast cancer. 30: 92-100."},{"key":"e_1_3_2_1_3_1","volume-title":"He X and Perou CJBcrB","author":"Prat A","year":"2010","unstructured":"Prat A , Parker J , Karginova O , Fan C , Livasy C , Herschkowitz J , He X and Perou CJBcrB . 2010 . Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. 12: R68. Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz J, He X and Perou CJBcrB. 2010. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. 12: R68."},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Lee W and Boyer TJL. 2001. BRCA1 and BRCA2 in breast cancer. S5.  Lee W and Boyer TJL. 2001. BRCA1 and BRCA2 in breast cancer. S5.","DOI":"10.1016\/S0140-6736(01)07018-0"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2016.06.005"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0111-2"},{"key":"e_1_3_2_1_7_1","first-page":"2804","article-title":"Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases","volume":"36","author":"Ramakrishna N","year":"2018","unstructured":"Ramakrishna N , Temin S , Chandarlapaty S , Crews J , Davidson N , Esteva F , Giordano S , Kirshner J , Krop I , Levinson J , Modi S , Patt D , Perlmutter J , Winer E and Lin NJJocoojotASo CO. 2018 . Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases : ASCO Clinical Practice Guideline Update. 36 : 2804 - 2807 . Ramakrishna N, Temin S, Chandarlapaty S, Crews J, Davidson N, Esteva F, Giordano S, Kirshner J, Krop I, Levinson J, Modi S, Patt D, Perlmutter J, Winer E and Lin NJJocoojotASoCO. 2018. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update. 36: 2804-2807.","journal-title":"ASCO Clinical Practice Guideline Update."},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0100TR"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Wee P and Wang Z. 2017. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basel) 9:  Wee P and Wang Z. 2017. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basel) 9:","DOI":"10.3390\/cancers9050052"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.11.002"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0561-8"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091139"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.74"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells3020199"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2992089"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203973"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4917-1"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.13.4265-4275.2001"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01950-05"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07112"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx247"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002"},{"key":"e_1_3_2_1_23_1","volume-title":"Uhl\u00e9n M and Lundberg E","author":"Thul PJ","year":"2017","unstructured":"Thul PJ , \u00c5kesson L , Wiking M , Mahdessian D , Geladaki A , Ait Blal H , Alm T , Asplund A , Bj\u00f6rk L , Breckels LM , B\u00e4ckstr\u00f6m A , Danielsson F , Fagerberg L , Fall J , Gatto L , Gnann C , Hober S , Hjelmare M , Johansson F , Lee S , Lindskog C , Mulder J , Mulvey CM , Nilsson P , Oksvold P , Rockberg J , Schutten R , Schwenk JM , Sivertsson \u00c5, Sj\u00f6stedt E , Skogs M , Stadler C , Sullivan DP , Tegel H , Winsnes C , Zhang C , Zwahlen M , Mardinoglu A , Pont\u00e9n F , von Feilitzen K , Lilley KS , Uhl\u00e9n M and Lundberg E . 2017 . A subcellular map of the human proteome. Science . 356. Thul PJ, \u00c5kesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, Alm T, Asplund A, Bj\u00f6rk L, Breckels LM, B\u00e4ckstr\u00f6m A, Danielsson F, Fagerberg L, Fall J, Gatto L, Gnann C, Hober S, Hjelmare M, Johansson F, Lee S, Lindskog C, Mulder J, Mulvey CM, Nilsson P, Oksvold P, Rockberg J, Schutten R, Schwenk JM, Sivertsson \u00c5, Sj\u00f6stedt E, Skogs M, Stadler C, Sullivan DP, Tegel H, Winsnes C, Zhang C, Zwahlen M, Mardinoglu A, Pont\u00e9n F, von Feilitzen K, Lilley KS, Uhl\u00e9n M and Lundberg E. 2017. A subcellular map of the human proteome. Science. 356."},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular portraits of human breast tumours. 2012. Nature. 490: 61-70.  Comprehensive molecular portraits of human breast tumours. 2012. Nature. 490: 61-70.","DOI":"10.1038\/nature11412"},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307"},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.10.002"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0334"},{"key":"e_1_3_2_1_28_1","volume-title":"Bhattacharya A and Zhang Y","author":"Yang L","year":"2019","unstructured":"Yang L , Li Y , Bhattacharya A and Zhang Y . 2019 . A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer. Sci Transl Med . 11. Yang L, Li Y, Bhattacharya A and Zhang Y. 2019. A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer. Sci Transl Med. 11."},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03992.x"},{"key":"e_1_3_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.12.95"},{"key":"e_1_3_2_1_31_1","volume-title":"Hutchinson L and Cosar E F","author":"Sakhdari A","year":"2015","unstructured":"Sakhdari A , Hutchinson L and Cosar E F . 2015 . Molecular Pathology of HER Family of Oncogenes in Breast Cancer : HER-2 Evaluation and Role in Targeted Therapy. Springer New York . 119-136 Sakhdari A, Hutchinson L and Cosar E F. 2015. Molecular Pathology of HER Family of Oncogenes in Breast Cancer: HER-2 Evaluation and Role in Targeted Therapy. Springer New York. 119-136"},{"key":"e_1_3_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Ueno N and Zhang DJJoC. 2011. Targeting EGFR in Triple Negative Breast Cancer. 2: 324-328.  Ueno N and Zhang DJJoC. 2011. Targeting EGFR in Triple Negative Breast Cancer. 2: 324-328.","DOI":"10.7150\/jca.2.324"},{"key":"e_1_3_2_1_33_1","first-page":"1609","article-title":"A perspective on anti-EGFR therapies targeting triple-negative breast cancer","volume":"6","author":"Nakai K","year":"2016","unstructured":"Nakai K , Hung MC and Yamaguchi H. 2016 . A perspective on anti-EGFR therapies targeting triple-negative breast cancer . Am J Cancer Res. 6 : 1609 - 1623 . Nakai K, Hung MC and Yamaguchi H. 2016. A perspective on anti-EGFR therapies targeting triple-negative breast cancer. Am J Cancer Res. 6: 1609-1623.","journal-title":"Am J Cancer Res."},{"key":"e_1_3_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2289-9"},{"key":"e_1_3_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199212000-00006"},{"key":"e_1_3_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1945"},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2011.648617"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.42"},{"key":"e_1_3_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01147"},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000431"},{"key":"e_1_3_2_1_41_1","first-page":"139","article-title":"Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members","volume":"327","author":"Marchese A.","year":"2006","unstructured":"Marchese A. 2006 . Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members . Methods Mol Biol. 327 : 139 - 145 . Marchese A. 2006. Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members. Methods Mol Biol. 327: 139-145.","journal-title":"Methods Mol Biol."},{"key":"e_1_3_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.175"},{"key":"e_1_3_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31657"},{"key":"e_1_3_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32616-2"},{"key":"e_1_3_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep33825"},{"key":"e_1_3_2_1_46_1","volume-title":"Engelman JA and Jain RK","author":"Kodack DP","year":"2017","unstructured":"Kodack DP , Askoxylakis V , Ferraro GB , Sheng Q , Badeaux M , Goel S , Qi X , Shankaraiah R , Cao ZA , Ramjiawan RR , Bezwada D , Patel B , Song Y , Costa C , Naxerova K , Wong CSF , Kloepper J , Das R , Tam A , Tanboon J , Duda DG , Miller CR , Siegel MB , Anders CK , Sanders M , Estrada MV , Schlegel R , Arteaga CL , Brachtel E , Huang A , Fukumura D , Engelman JA and Jain RK . 2017 . The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation. Sci Transl Med . 9: Kodack DP, Askoxylakis V, Ferraro GB, Sheng Q, Badeaux M, Goel S, Qi X, Shankaraiah R, Cao ZA, Ramjiawan RR, Bezwada D, Patel B, Song Y, Costa C, Naxerova K, Wong CSF, Kloepper J, Das R, Tam A, Tanboon J, Duda DG, Miller CR, Siegel MB, Anders CK, Sanders M, Estrada MV, Schlegel R, Arteaga CL, Brachtel E, Huang A, Fukumura D, Engelman JA and Jain RK. 2017. The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation. Sci Transl Med. 9:"},{"key":"e_1_3_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1843"},{"key":"e_1_3_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.05.010"},{"key":"e_1_3_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169417"},{"key":"e_1_3_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0388-5"},{"key":"e_1_3_2_1_51_1","first-page":"733","article-title":"A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK","volume":"7","author":"Dey N","year":"2015","unstructured":"Dey N , Williams C , Leyland-Jones B and De P. 2015 . A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK . Am J Transl Res. 7 : 733 - 750 . Dey N, Williams C, Leyland-Jones B and De P. 2015. A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK. Am J Transl Res. 7: 733-750.","journal-title":"Am J Transl Res."},{"key":"e_1_3_2_1_52_1","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-18-0430","article-title":"HER2 Amplification in Tumors Activates PI3K\/Akt Signaling Independent of HER3","volume":"78","author":"Ruiz-Saenz A","year":"2018","unstructured":"Ruiz-Saenz A , Dreyer C , Campbell MR , Steri V , Gulizia N and Moasser MM. 2018 . HER2 Amplification in Tumors Activates PI3K\/Akt Signaling Independent of HER3 . Cancer Res. 78 : 3645 - 3658 . Ruiz-Saenz A, Dreyer C, Campbell MR, Steri V, Gulizia N and Moasser MM. 2018. HER2 Amplification in Tumors Activates PI3K\/Akt Signaling Independent of HER3. Cancer Res. 78: 3645-3658.","journal-title":"Cancer Res."},{"key":"e_1_3_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4148791"},{"key":"e_1_3_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.06.037"},{"key":"e_1_3_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12485"},{"key":"e_1_3_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2368"},{"key":"e_1_3_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2195-3"},{"key":"e_1_3_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2014.994966"}],"event":{"name":"ICBBT '21: 2021 13th International Conference on Bioinformatics and Biomedical Technology","acronym":"ICBBT '21","location":"Xi'an China"},"container-title":["2021 13th International Conference on Bioinformatics and Biomedical Technology"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3473258.3473270","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3473258.3473270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:28:15Z","timestamp":1750195695000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3473258.3473270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":58,"alternative-id":["10.1145\/3473258.3473270","10.1145\/3473258"],"URL":"https:\/\/doi.org\/10.1145\/3473258.3473270","relation":{},"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"2021-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}